PBS Website Update - 1 May 2016
Page last updated: 1 May 2016
The Schedule of Pharmaceutical Benefits was updated on 1 May 2016 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website:
- Therapeutic Relativity Sheets - 1 May 2016
- Drugs subject to Price Disclosure - 1 May 2016
- Ex-manufacturer price - 1 May 2016
- Formulary Allocations - 1 May 2016
- Items Exempt from Statutory Price Reductions - 1 May 2016
- Listings on the PBS for Aboriginal and Torres Strait Islander people - 1 May 2016
- Updated Hepatitis C Factsheets - 1 May 2016
- General Statement for Drugs for the Treatment of Hepatitis C - 1 May 2016
- Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer - 1 May 2016
- PBS and RPBS Section 85 Date of Processing and Date of Supply Data - 29 April 2016
- PBAC Cycle Timeframes- 2016-2018 - 29 April 2016
- Post-Market Review of Authority Required PBS Listings - 29 April 2016
- PBAC Meeting Agenda and Consumer Comments - 28 April 2016
- Agenda for the July 2016 PBAC Meeting - 28 April 2016
- Recommendations made by the PBAC - March 2016 - 22 April 2016
- Record of Stakeholder Meeting - Eculizumab (Soliris®) for Atypical Haemolytic Uraemic Syndrome (February 2016) - 22 April 2016
- Post-market Reviews of Medicines to treat PAH and bDMARDs to treat Severe Chronic Plaque Psoriasis - 22 April 2016
- Generic Medicines Working Group Communique - 21 April 2016
- Generic Medicines Working Group Work Plans - 21 April 2016
- PBAC Public Summary Documents - November 2015 meeting - 18 April 2016
- Price Disclosure - Drugs and manners of administration that meet the F2/multi-branded criteria (30 month clock for originator removal calculation) for the 2016 October Cycle - 12 April 2016
- PBAC Guidelines Review - Public Consultation on co-dependent technology chapter - 12 April 2016
- PBAC Guidelines Review - Public Consultation on draft revised PBAC Guidelines now closed - 7 April 2016
